Why did reported EPS jump 39% while adjusted EPS rose only 6%?

The reported figure includes a $250 million pre-tax gain on divestitures, worth about $1.91 per diluted share. Excluding that gain and other non-GAAP items such as acquired intangible amortization and business realignment charges, adjusted EPS was $6.53, up 6% from $6.15. Investors generally treat the adjusted figure as the better gauge of core earnings power.

How healthy is the Aerospace Systems segment compared with Diversified Industrial?

Aerospace Systems is the clear standout, with sales up 14% organically, an adjusted segment margin of 28.2% (up 170 bps), and orders up 9%, driven by a 20%+ aftermarket growth rate. Diversified Industrial is weaker, with organic sales down about 4% in the quarter, continued softness in transportation, off-highway, and Europe, and only early signs of recovery in North America orders. Aerospace is carrying much of the company's growth.

Is the company's balance sheet and cash flow improving?

Yes. Year-to-date operating cash flow rose 24% to $1.68 billion, and free cash flow reached $1.46 billion, up 27%. Debt reduction of roughly $1.1 billion this quarter, funded partly by about $0.6 billion of divestiture proceeds, lowered leverage. Management says the strong cash generation gives it capital deployment flexibility, including potential share repurchases or acquisitions.

What changed in FY25 guidance and what are the key risks?

Reported sales guidance is now (2%) to 1%, with organic growth of about 2%, reflecting currency headwinds of about 1% and divestitures of about 1.5%. Adjusted EPS guidance is $26.40 to $27.00. Aerospace organic growth was raised to about 11%, but management delayed its expected industrial recovery. Key risks include a prolonged industrial downturn, weakness in European and off-highway markets, currency movements, and tariff or supply chain disruptions noted in the forward-looking statements.

PH 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed January 30, 2025. Cited figures are marked; the original filing is the authoritative source.

Parker-Hannifin's fiscal Q2 2025 results (quarter ended December 31, 2024) showed mixed headline numbers with strong underlying profitability.

Reported net sales were $4.74 billion^a, down 1.6% year over year, with organic growth of only about 1% (0.7% per the company's reconciliation). Reported diluted EPS rose 39% to $7.25, but this was inflated by a $250 million gain on divestitures (about $1.91 per share). On an adjusted basis, EPS was $6.53, up 6%, and adjusted segment operating margin reached a record 25.6%, up 110 basis points.

Management highlighted operational excellence and a 14% organic growth surge in Aerospace Systems, while Diversified Industrial remained soft, with continued weakness in transportation, off-highway, and Europe. Cash generation and balance sheet repair were the clearest positives. Year-to-date operating cash flow rose 24% to $1.68 billion^b, or 17.4% of sales, and free cash flow reached $1.46 billion.

Proceeds from divestitures helped reduce debt by roughly $1.1 billion^c in the quarter, and total debt fell meaningfully from June 2024 levels. Order rates were positive across all reported businesses, with Parker-wide orders up 5%, North America industrial orders turning positive on long-cycle strength, and Aerospace orders up 9%. The company trimmed some guidance elements while raising others.

FY25 sales guidance is now (2%) to 1% reported, with organic growth of about 2%, reflecting stronger Aerospace (now about 11% organic growth) offset by currency headwinds and a continued delay in the expected industrial recovery. Adjusted EPS guidance is $26.40 to $27.00^d, and free cash flow guidance is $3.0 billion to $3.3 billion. Investors should weigh the strong margin and cash execution against a still-soft industrial backdrop and reliance on the Aerospace aftermarket cycle.

02—Key points

Key Highlights

Reported diluted EPS of $7.25 (up 39%) includes a ~$1.91/share gain on divestitures; adjusted EPS of $6.53 rose 6% YoY, the more relevant comparison for core earnings.
Record adjusted total segment operating margin of 25.6%, up 110 bps, with record adjusted margins in Aerospace (28.2%), North America industrial (24.6%), and International industrial (24.1%).
Net sales of $4.74 billion fell 1.6% reported; organic growth was roughly flat (+0.7%), with Aerospace up 14% organic offsetting Diversified Industrial down 4.2% organic.
Year-to-date operating cash flow grew 24% to $1.68 billion (17.4% of sales), and free cash flow rose 27% to $1.46 billion, supported by strong working capital and divestiture proceeds.
Debt was reduced by about $1.1 billion in the quarter, with total debt falling to roughly $9.0 billion from about $10.6 billion at fiscal year-end June 2024, reflecting divestiture proceeds and cash generation.
Orders rose 5% company-wide, with Aerospace up 9%, North America industrial orders turning positive on long-cycle strength, and International orders up 4%, led by Asia.
FY25 guidance updated: reported sales (2%) to 1%, organic growth about 2%, adjusted EPS $26.40 to $27.00, and free cash flow $3.0 billion to $3.3 billion; Aerospace organic growth raised to about 11%, while the industrial recovery timeline was pushed out.

03—Questions

Frequently Asked Questions

Why did reported EPS jump 39% while adjusted EPS rose only 6%?
The reported figure includes a $250 million pre-tax gain on divestitures, worth about $1.91 per diluted share. Excluding that gain and other non-GAAP items such as acquired intangible amortization and business realignment charges, adjusted EPS was $6.53, up 6% from $6.15. Investors generally treat the adjusted figure as the better gauge of core earnings power.
How healthy is the Aerospace Systems segment compared with Diversified Industrial?
Aerospace Systems is the clear standout, with sales up 14% organically, an adjusted segment margin of 28.2% (up 170 bps), and orders up 9%, driven by a 20%+ aftermarket growth rate. Diversified Industrial is weaker, with organic sales down about 4% in the quarter, continued softness in transportation, off-highway, and Europe, and only early signs of recovery in North America orders. Aerospace is carrying much of the company's growth.
Is the company's balance sheet and cash flow improving?
Yes. Year-to-date operating cash flow rose 24% to $1.68 billion, and free cash flow reached $1.46 billion, up 27%. Debt reduction of roughly $1.1 billion this quarter, funded partly by about $0.6 billion of divestiture proceeds, lowered leverage. Management says the strong cash generation gives it capital deployment flexibility, including potential share repurchases or acquisitions.
What changed in FY25 guidance and what are the key risks?
Reported sales guidance is now (2%) to 1%, with organic growth of about 2%, reflecting currency headwinds of about 1% and divestitures of about 1.5%. Adjusted EPS guidance is $26.40 to $27.00. Aerospace organic growth was raised to about 11%, but management delayed its expected industrial recovery. Key risks include a prolonged industrial downturn, weakness in European and off-highway markets, currency movements, and tariff or supply chain disruptions noted in the forward-looking statements.

04—Continue

← View all 8-K filings